和铂医药控股有限公司（股票代码：02142，股票名称：和铂医药-B）于2026年5月19日发布公告，披露在香港联交所场内回购普通股50万股，占本次事件前已发行股本约0.0576%，每股回购价介乎12.06港元至12.54港元，合计约615.45万港元。上述股份将被列为公司库藏股。
公告显示，公司同日还根据其首次公开发售后股份奖励计划发行22,000股新股，占本次事件前已发行股本约0.0025%。本次回购与发行后，公司已发行股本为867,961,722股，库藏股数量为31,334,000股，总股本达899,295,722股。
根据公告，股东大会于2025年6月11日通过购回授权，公司可回购总数约82,834,612股股份。截至目前，公司已于香港联交所或其他证券交易所累计回购股份12,997,000股，占上述授权通过当日已发行股本约1.57%。
公司在公告中确认已遵守香港联交所证券上市规则及相关法律法规。该公告由执行董事王劲松签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.